Загрузка...
Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
Psoriasis is a chronic immune-mediated disease involving complex interaction of T cells and keratinocytes. The comprehensive pathogenesis of psoriasis is not fully understood but the IL-23/Th17 axis is a central pathway in driving disease development. Guselkumab is the first treatment of moderate-to...
Сохранить в:
| Опубликовано в: : | Clin Cosmet Investig Dermatol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815086/ https://ncbi.nlm.nih.gov/pubmed/33488109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S235242 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|